Objective: To measure patient preferences for their diabetic care in community setting. Design: Discrete-choice survey. Setting: Community setting (primary physician and hospital sites) in Cyprus. Participants: Diabetic patients attending community sites. Main Outcome Measure(s): Patient preferences, to estimate which components of quality healthcare service people value, their relative importance but also the potential shift to shared decisionmaking (SDM). Results: Older respondents with experience of the private sector already received SDM (managing their care and choosing their treatments; detailed and accurate information, continuity of care; compassion for their personal situation) from their primary care physician with waiting time shorter than 1 h. They valued their 'current' option and they did not want to change it with other services. Younger people from the public sector valued a change in policy and wanted to move from their 'current' to alternative diabetic care services where the waiting times were shorter, they could not only manage their care but also choose their treatments (together with receiving information, continuity of care and compassionate care). Individuals agreed with receiving multidisciplinary care from a team of healthcare providers but they mostly preferred being supported by their primary care physician. The pooled sample valued their 'current' option but they also supported policy changes that would implement SDM service for everybody. Conclusions: Diabetic patients value SDM and are willing to support a shift of practice to receive it not only in the private but also in the public sector. The forthcoming National Health Insurance Service would aim to address such developments as anticipated both in the European Troika's recommendations and the relevant laws.
Introduction
Patient preferences for community care services have become an increasingly important aspect of healthcare policy in Europe; unfortunately, much of the evidence collected in the literature is related to Northern European countries and limited data are available on the Mediterranean area [1] . Cyprus, an eastern Mediterranean country that lacks of a universal coverage health system, is a quite unique case in Europe [2, 3] . A National Health Insurance System (NHIS), as put forward and approved by law, which has not yet been implemented, provides for inclusion and coverage of all citizens, equity in contribution and in treatment provision, bolstering of patients' rights, introduction of cost-containment policies towards the sustainability of the system, which will be applicable across the system, monitoring and medical audit control. Of particular interest is that none of these applies today in the private sector, while public sector travails to implement some of them [4, 5] . Pertinent to the patient's empowerment, the competent authority for the introduction of the NHIS, the Health Insurance Organization, has appointed a member of the patient's association in its board of directors, thus streamlining its operational framework with the need to engage patients and also solidifying its support regarding the active role of patients in the decision-making process.
Current healthcare sector features two fragmented systems, public and private sectors, which run in an uncoordinated and parallel way, with minimum cooperation, duplication of infrastructures and failure to achieve economies of scale, a significant aspect in Cyprus small healthcare market. We should underline that the two sectors are subject to different legislations, which further broadens the gap and perpetuates to inequity among patients. For instance, patient's right officers are employed only in public hospitals. Moreover, private hospitals cannot operate pharmacies, while public do.
The public sector provides free healthcare to a series of highly prevalent chronic conditions including diabetes (Patients in the public sector are subject to co-payment which come in the form of a fixed fee for physicians (3 euro for GP, 6 euro for specialists) and 0.5 euro for each medicine and laboratory test (both capped at 10 per prescription/ laboratory order form)) [6] , affecting about 9.2% of the Cypriot population, well above the average of 6.1% in the European Union [7] . An estimated 4 million euros (corresponding to the 5% of total pharmaceutical expenditure of public sector) is allocated for antidiabetic agents in the public healthcare sector. In the private sector, the corresponding amount is 3.4 million euros, nevertheless, volume-wise public sector consumes significantly more quantities more since it procures medicines through tendering, which plummets prices as low as 62% in the generics and 25% for branded products. This underlines another difference between the two sectors, diverging pricing approaches, which further compound the affordability issues of private sector patients, who pay all costs out-of-pocket. The overall impact of endocrine-related diseases and conditions including diabetes translates in about 10% of the total annual healthcare expenditure (1.2 billion euro) for the country [8] .
Overall 85% of total population who fulfil certain socioeconomic and employment status criteria are eligible for free public healthcare funded by the Ministry of Health, on a highly centralised context. The array of eligibility criteria is rather biased, which violates equity in access and favours some cohorts of the population. This leads to a grossly uneven access to public healthcare [9] . The Public sector reimburses pharmaceuticals (including consumables and diagnostics) from a tender-based closed formulary, while the Private sector applies external price referencing. Failure of patients to tolerate or respond to the formulary products force them to the Private sector, whose affordability for patients has proven to be highly problematic [10] . Although there is freedom of choice and the majority of the population are eligible for free public healthcare, out-of-pocket payment remains the primary source of healthcare funding indicating that people may disparage public healthcare, because of perceived issues of quality and long waiting times [11] . Cost of private sector is borne out-of-pocket unless patient is covered by an optional private health insurance.
These attributes of Cyprus health system led to an oversupply of private sector, as illustrated by the second highest number per capita in Europe of high-cost technologies (e.g. computerized tomography scanners). This leads to high running cost that, in the context of the private sector, are shifted to private patients [12] . The inertias of the system are further aggravated by minimum adoption of information technology, which leads to lack of coordination, and interruption of continuity of care both between public and private, but also between public primary and secondary care sectors, resulting in duplication of diagnostic activities. The lack of clinical guidelines has impeded the introduction of benchmarking and the consequent definition of performance targets, which unavoidably results into major variability of health outcomes among health centres [13, 14] . These features also limited monitoring and medical auditing.
Although a number of the issues delineated above are experienced also in other Northern European countries featuring uncoordinated private and public systems (see for example, the Republic of Ireland), Cyprus constitutes a quite unique case study to assess the provision of quality of healthcare in a challenging environment, that is still burdened by the ramifications of the fiscal crisis, that has further impeded the affordability of patients, which intertwined with access, especially in the private healthcare sector. This is further substantiated by the existence of only scarce data. So far, four patient satisfaction surveys were conducted [14] [15] [16] [17] [18] . Unfortunately, they were too broad and did not considered specific needs and opinions for diabetic patients looking for community care services and did not include any notion of strength of preference and relative importance between attributes of care.
Current paper offers a unique perspective on decision-making criteria among Cyprus, using for the first time the discrete-choice experiment (DCE) approach [19] [20] [21] [22] [23] [24] to capture Cypriot preferences for community care services across private and public sectors. DCE is an economic tool that can be used to study preferences for variety of healthcare services [20] , including diabetes care [24] . Its application to community care allowed to inform decisions about quality care interventions to be implemented [25] [26] [27] . This particular application investigated Cypriot patients' preferences when choosing community care services for their diabetes care, and how they value shared decision-making (SDM) [26] [27] [28] [29] , as a process in which healthcare professionals and patients work together to select tests, treatments, management or support packages, based on clinical evidence and patients' informed preferences. In the field of SDM, no studies have been performed in Cyprus, although some authors highlighted this lack and urged for its implementation [2] .
Results from the DCE allowed to estimate the components of SDM that people value, their relative importance; and the potential willingness to shift to alternative healthcare services (compared with their 'current' option). Differences in preferences are presented across sectors.
Methods
The DCE questionnaire A description of the DCE questions is presented in here (see example in Fig. 1) ; however, more details are provided in Appendix 1 on: the DCE choice set creation; questionnaire design and development; feasibility and piloting; theoretical validity; preparation for data collection and analysis; and ethical approval. First, respondents were asked to describe their 'current' option in terms of six characteristics:
• Information-whether they (rarely/never; sometimes; most of the times; always) receive detailed and accurate information about their care; • Compassion-whether they (rarely/never; sometimes; most of the times; always) receive care and compassion for their personal situation; • Care management-whether they can choose treatment options and manage care (I can choose my treatment options and manage my care; I can only choose my treatment options; I can only manage my care; none of them); • Waiting time-their waiting time at the site (<1 h; 1 h; 2 h; 3 h or more); • Continuity of care-whether they receive community care from the same healthcare professional (primary care physician/nurse/ specialist doctor); • Who is providing care-the healthcare provider(s) delivering their care (primary care physician only; primary care physician and nurse; hospital physician/specialist only; hospital physician/specialist and nurse; primary care physician, hospital physician/specialist and nurse).
Following that, patients were then asked to complete a set of four DCE choices about their most preferred healthcare service. Each choice compared three separate alternatives ('hypothetical Alternative A', 'hypothetical Alternative B' and their 'current' option described by combinations of the same attributes and levels used above; see Appendix 1). The set of choices was created according to best practice in the design of DCE (details are in Appendix 1). An additional set of questions addressed patients' socio-demographic characteristics and health status.
Data collection, sample and sample size
Seven separate community sites were involved in the study (four public and three private sites; see Appendix 2). They were chosen as a convenience sample of data collection sites distributed between urban and rural locations. A target recruitment of about 100 patients from public and private sites was estimated to be sufficient for comparing preferences across settings [30] . The questionnaire was administered to diabetic patients aged 18 years or older whilst attending the community clinics. Subjects that were too ill to listen to the researcher were excluded from the study. A researcher was available during data collection in the community site to provide clarification and assistance in completing the questionnaire. After giving their signed consent, respondents were invited to complete a questionnaire either whilst waiting (with the option of completing it after the consultation) or later at home (to be returned to the site at their convenience).
Analysis of data
Only questionnaires with a completed DCE choice set and section on their 'current' option were considered for analysis. Results from the raw statistics and regression model are presented for the pooled data ('all Cyprus') and for the two specific subgroups ('Cyprus public' vs. 'Cyprus private'). Site characteristics, patient responses, aspects of their 'current' option and demographic characteristics were analysed using raw statistics. Categorical data were described using frequencies and percentages, whilst continuous data were described with a mean and standard deviation. Differences between groups ('Cyprus all' vs. 'Cyprus public'/'Cyprus private'; 'Cyprus public' vs. 'Cyprus private') were tested using Chi-squared and t independent group statistics for categorical and continuous variables, respectively.
The utility or satisfaction function, which specifies the relationship between the attributes and preferences, was derived from the DCE choice set and estimated using an appropriate regression model (see Appendix 3) [31] .
Comparing policy changes across groups
Two examples of change in healthcare practice were proposed (change in healthcare practice 1, from 'current' option to hypothetical 'Alternative diabetic service 1', and change in healthcare practice 2, from 'current' option to hypothetical 'Alternative diabetic service 2'). Details on the actual characteristics attached to the alternative healthcare practices are presented in the results below. 'Alternative diabetic services 1 and 2' were chosen to reflect the preferred attribute levels' combinations from the patient preferences. Measure of patient satisfaction for the two proposed policy changes (compared with 'current' option) is provided by probability of uptake for changes; details are presented in Appendix 4.
Results
Community sites, patient responses and their sociodemographic characteristics Between July and September 2014, 192 eligible patients were identified across seven community sites (see Appendix 1). In the public and private subgroups, 92 and 72 eligible patients who received the survey completed it (90.2% and 80.0%, respectively; see Table 1 ). Overall, 162 (84.3%) questionnaires were used for analysis, 90 (88.2%) in public and 72 (80%) in private settings. Individuals attending the private setting were older with more comorbidities but reported a better health status than those in the public setting (P < 0.01; more in Table 2 ).
Patient 'current' option Current experience of diabetic care was positive across settings, and characterised by (Appendix 5, 'Cyprus all'): (i) receiving detailed and accurate information about their care, most of the times/Always, 96%; (ii) receiving care and compassion for their personal situation, most of the times/Always 95%; (iii) choosing treatment options and manage my care 43%; (iv) 1 h or less waiting time at the site 77%; (v) receiving community care from the same healthcare provider 88% and (vi) receiving care from the primary care physician/primary care physician and nurse 64%. When looking at the setting-specific data, attributes' levels combination for the 'current' option varied across groups (see Appendix 5). 'Cyprus private' presented the best attribute combinations in terms of information (100% most of the times/always), compassion (100% most of the times/always), care management (100% managing their care, either alone or together with choosing treatment option), waiting time (100% 1 h or less) and continuity of care (80%). The healthcare provider mostly approached in the private setting was the primary care physician (alone or with the primary care nurse, 96%). Difference across the three groups are presented in Appendix 5.
Patient preferences
Results confirmed the theoretical validity of responses (see Appendix 6) . Respondents from 'Cyprus private' presented constant preference for their 'current' option and were not willing to trade for any alternative hypothetical service. DCE output are presented for the pooled sample 'Cyprus all' and subgroup 'Cyprus public' (see Appendix 6) . Overall respondents from 'Cyprus all' valued: receiving detailed and accurate information about their care (always/most of the times); receiving compassionate care (always/most of the times); choosing treatment options and managing their care; continuity of care and receiving community from their primary care physician. The three most preferred service characteristics were: receiving community from their primary care physician (compared with hospital sites); receiving 'always' care and compassion for their personal situation and receiving 'always' detailed and accurate information about their care. Waiting time was the least valued characteristic. More details are in Appendix 6.
Policy changes
When comparing patient preferences across settings, the probability of uptake for alternative diabetes care services are easily interpretable measure of the relative importance placed on specific policy changes (listed in Table 3 ), and Fig. 2 reports the results of this exercise. Both 'Cyprus all' and 'Cyprus public' wanted to change from their 'current' option to 'alternative diabetic services'. For both groups, the preferred policy change was represented by the shift to the 'alternative diabetic services 2' (probability of uptake was 90% for 'Cyprus all' compared with 96% for 'Cyprus public') offering: 'always' detailed and accurate information about their care'; 'always' care and compassion for their personal situation'; the opportunity to both 'choose their treatment options, and manage their care'; 50% decrease in their 'waiting time' and 'care delivered by the physician, the hospital specialist and nurse'.
Discussion
This paper shows that Cypriot value SDM processes regarding their care for diabetes regardless of whether they seek private or public treatments. Private patients (who were already involved in SDM and supported by their primary care physician) presented constant preference for their 'current' option and were not willing to trade for alternative hypothetical services (status quo bias, where people are more likely to adopt a conservative response to health services innovations; see Tinelli et al [26] ).
Respondents from the public setting were younger people and had already some experience of what is regarded as SDM; however, they could not 'choose their treatment options and manage their care', and their average 'waiting time' at the clinics was longer than 1 h (both aspects highly valued by the respondents). Overall, they valued a shift in policy and wanted to move from their current 'option' to 'alternative diabetic care services' where the waiting times were shorter, they could not only manage their care but also choose their treatments, whilst receiving 'always detailed and accurate information about their care', 'care and compassion for their personal situation' and 'continuity of care'. Individuals did value a team of multidisciplinary healthcare providers (change to service 1) but they preferred to receive support from their primary care physician (change to service 2).
The 'all Cyprus' sample valued their 'current' option but they were willing to change to 'alternative diabetic care services' where they could experience shorter waiting times, and be involved more a: Questionnaires were distributed to the patients attending the community site by a member of the local research team; b: Questionnaires returned to the research team with attached consent form either at the community site or by post.
c: Only questionnaires with completed DCE choice set and 'current' option levels were considered for analysis.
Note: differences between groups (Cyprus total vs. public/private; Cyprus public vs. private) were not significant at 0.05 level. in SDM. Again, support from their primary care physician was preferred to coordinated care from a multidisciplinary team of healthcare professionals. It may be argued that, although over the past two decades [32] , most health systems have reoriented diabetes care from acute services to regular integrated management in the community setting, Cypriots are still very new to the concept of coordination between primary-secondary settings and they have still limited opportunities to experience it across private and public sectors. Diabetes is particularly challenging to coordinate given the multiple healthcare providers and settings involved. International emphasis is now on integrated care which focuses on the organization of management within settings and the coordination of care between settings [33] [34] . The overall findings from this Cypriot case study emphasise the need to implement anticipated more person-centred healthcare system that would seek to unify public and private resources in a way that would allow patients to decide, on their own, the service provider who will fit their needs [12, 35] . The documented patient value of shorter waiting times, more personalized care, more information can be satisfied only within the context of a person-centred healthcare system which will redistribute existing resources in more efficient allocation, allow people to choose their provider and support a quality performance scheme. The latter has proven to be very useful when promoting interaction between clinicians and their patients. Unfortunately, we can anticipate that the public healthcare sector in Cyprus is highly unlikely to adopt to the findings of this study since currently, there is recruitment freeze, an austerity measure and many physicians leave public sector for the more profitable private sector, a trend which is aggravated by constant reduction in their remuneration-again an austerity measure [2] . Consequently, public sector cannot cope effectively with patient's demands and adjust to its new (expected) mode of action since demand has exceeded its functional capacity. The same applies for the private sector, which is totally financed by out-of-pocket payment, an attribute that leaves patients exposed to large health expenditure and violates the principles of healthcare provision, namely equity and solidarity, by not cross-subsidising both from rich to poor and from people at low risk of illness to people with higher risks. When comparing Cyprus to an alternative European setting such as, the UK where person-centred practices are already in place we found that Cypriots valued choosing alternative SDM services compared with their 'current' option, whereas the English preferred their status quo to other services [36] . Several of these issues can be imputed to the lack of a universal coverage system. Indicatively, patient campaigns, medical audit and other efficiency enhancement activities such as electronic prescribing, performance management have been programmed once the NHIS is on, therefore is anticipated that this will address, at least to a certain degree some of our findings. This was also one of the European Troika's recommendations as well, prior to the implementation of the bail-out agreement. Future work should allow to expand the limited sample size of this application (representing only 0.2% of the 89 700 overall diabetes population in Cyprus) and allow to capture the levels of interest for the introduction of SDM not just within the diabetes but also within the overall patient community in Cyprus compared with other healthcare systems with similar issues.
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